| abstract |
Peptides and peptide variants are provided herein that exhibit different activity in the GLP-1 receptor in composition with the natural glucagon. Claim 1: A peptide comprising or consisting of the amino acid sequence of the: a) SEQ ID NO. 17; b) SEQ ID No. 12; c) SEQ ID No. 13; d) SEQ ID No. 14; e) SEQ ID No. 15, or f) SEQ ID No. 16; or a pharmaceutically acceptable salt thereof. |